Conestoga Capital Advisors released its third-quarter 2025 investor letter, noting equity markets reaching new highs. The Conestoga Smid Cap Composite returned -1.1% net-of-fees, underperforming the Russell 2500 Growth Index at +10.7%. Check the top 5 holdings for insights into their 2025 picks. West Pharmaceutical Services, Inc. (NYSE: WST) saw a one-month return of 6.18% and a stock price of $270.60 on October 17, 2025.

In the investor letter, Conestoga Capital Advisors discussed West Pharmaceutical Services, Inc. (NYSE: WST) and its specialized packaging and delivery systems for pharmaceuticals. The company experienced growth in high-value packaging due to increased demand for biologics and injectable therapies. Investor confidence rose with strong cash generation and a solid balance sheet.

West Pharmaceutical Services, Inc. (NYSE: WST) is not among the 30 Most Popular Stocks Among Hedge Funds. While the company shows promise, other AI stocks may offer better upside potential with lower risk. For an undervalued AI stock poised to benefit from trends like Trump-era tariffs, consider exploring the best short-term AI stock.

Read more at Yahoo Finance: Improved Investor Confidence Boosted West Pharmaceutical Services (WST)